Open Access BASE2018

Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies

Rondy M; Kissling E; Emborg H.-D; Gherasim A; Pebody R; Trebbien R; Pozo F; Larrauri A; McMenamin J; Valenciano M; Kaic B; Filipovic S.K; Visekruna-Vucina V; Novosel I.P; Lovric Z; Petrovic G; Krause T.G; Fische T.K; Lina B; Falchi A; Vilcu A.-M; Souty C; Blanchon T; van der Werf S; Enouf V; Behillil S; Valette M; Bernard-Stoecklin S; Levy-Bruhl D; Launay O; Loulergue P; Lenzi N; Lesieur Z; L'Honneur A.-S; Galtier F; Agostini C; Serrand C; Merle C; Foulongne V; Vanhems P; Laine F; Lagathu G; Carrat F; Buda S; Preuss U; Prahm K; Schweiger B; Wedde M; Heider A; Martin M; Biere B; Duerrwald R; Domegan L; Coughlan L; O'Donnell J; Joyce M; Collins C; Dunford L; Moran J; Tuite G; Duffy M; Connell J; de Gascun C; Rizzo C; Bella A; Alfonsi V; Castrucci M.R; Puzelli S; Pagani E; Ghisetti V; Pariani E; Baldanti F; Palu G; D'Agaro P; Ansaldi F; Affanni P; Rossolini G.M; Camilloni B; Bagnarelli P; Sanguinetti M; Atripaldi L; Chironna M; Serra C; Vitale F; Germinario C; Orsi A; Manini I; Montomoli E; Napoli C; Orsi G.B; Casado I; Castilla J; Fernandino L; Martinez-Baz I; Ezpeleta G; Navascues A; Perez-Garcia A; Aguinaga A; Ezpeleta C; Meijer A; van den Brink S; van der Hoek W; Goderski G; Wijsman L; Bagheri M; Dijkstra F; de Lange M; Marzec T; Overduin P; Teirlinck A; Wentink E; Donker G; Marbus S; van Gageldonk-Lafeber R; Schneeberger P; van Oosterheert J.J; Schweitzer V; Groeneveld G; Nunes B; Machado A; Rodrigues A.P; Gomez V; Kislaya I; Guiomar R; Pechirra P; Cristovao P; Costa I; Panarra A; Corte-Real R; Pocas J; Peres M.J; Comas L.G; Marisquerena M.E.I; Galan J.C; Folgueira M.D; Carril F.G; Martinez R.S; Cilla G; Cenoz M.G; Rubio C.Q; Ochoa E.M; Blasco M; Duran J.G; Vanrell J.M; Reina J; Castrillejo D; Gherasim A.M; Delgado C; Oliva J; Casas I; Garcia M; Latorre M; Beamonte A.M.M; Sapina A.M; Amores M.O; Aizpurua A; Montes M; Zakikhany K; Brytting M; Wiman A; Carnahan A; Warburton F; Djennad A; Ellis J; Andrews N; Marques D; Cottrell S; Reynolds A; Gunson R; Galiano M; Lackenby A; Robertson C; O'Doherty M; Sinnathamby M; Yonova I; Moore C; Sartaj M; de Lusignan S; Zambon M; Moren A; Penttinen P

Open Access

Abstract

Between September 2017 and February 2018, influenza A(H1N1)pdm09, A(H3N2) and B viruses (mainly B/Yamagata, not included in 2017/18 trivalent vaccines) co-circulated in Europe. Interim results from five European studies indicate that, in all age groups, 2017/18 influenza vaccine effectiveness was 25 to 52% against any influenza, 55 to 68% against influenza A(H1N1)pdm09, -42 to 7% against influenza A(H3N2) and 36 to 54% against influenza B. 2017/18 influenza vaccine should be promoted where influenza still circulates.

Problem melden

Wenn Sie Probleme mit dem Zugriff auf einen gefundenen Titel haben, können Sie sich über dieses Formular gern an uns wenden. Schreiben Sie uns hierüber auch gern, wenn Ihnen Fehler in der Titelanzeige aufgefallen sind.